Highlights
/global-malaria-programme-(gmp)/office-of-the-director-(mdo)/gmp-annual-report-2024.jpg?sfvrsn=f2cd5db0_6 "gmp-annual-report-2024")
Publications
All →The Global technical strategy for malaria 2016–2030 was adopted by the World Health Assembly in May 2015. It provides a comprehensive framework to...
Global Malaria Programme operational strategy 2024-2030
As WHO's technical department for malaria, the Global Malaria Programme has an important role to play in leading the global response against this disease....
Integrated approach to management of skin-related neglected tropical diseases and common skin conditions
Neglected tropical diseases (NTDs) are a diverse group of disease conditions that disproportionately a£ect populations living in poverty, particularly...
Ending the neglect to attain the sustainable development goals: noma control: technical brief
This technical brief provides an evidence-based overview of noma to support implementation of the WHO road map for neglected tropical diseases 2021–2030...
Guiding principles for prioritizing malaria interventions in resource-constrained country contexts to...
In response to ever increasing financial constraints, the WHO Malaria and Neglected Tropical Disease Department and Regional Offices, in consultation with...
Operational manual on larval source management: control of Anopheles and Aedes mosquito vectors
This operational manual provides practical guidance for the establishment, management, implementation, monitoring and evaluation of larval source management...
Rabies is a neglected zoonotic disease caused by lyssaviruses and transmitted to humans primarily through the bites or scratches of infected animals,...
P. vivax contributes substantially to the malaria burden outside of sub-Saharan Africa. P.vivax requires medicines to eliminate both blood-stage...
Ways to access malaria guidance
Clear, evidence-informed WHO recommendations are designed to guide countries as they develop national malaria strategic plans; they support decisions around “what to do”.
/in-page-highlights/malaria-magicapp-square.png?sfvrsn=5377a7ae_23 "malaria-magicapp-square")
/in-page-highlights/malaria-toolkit-app-square_e84ff510-2b45-4bcf-97a7-ac89aadf011d.jpg?sfvrsn=bbe7d3f2_23 "malaria-toolkit-app-square")
/in-page-highlights/illustration-for-new-guidance.jpg?sfvrsn=396b72fa_3 "illustration-for-new-guidance")
/mme-images/mme-banner-small.jpg?sfvrsn=84d5cea_4 "mme-banner-small")
/malaria-vaccine-first-babies-500pix7b68b5bd00bf49a79517fea854f4cbf3_3becb335-06a4-43af-9b5b-56ef8683aef8.jpg?sfvrsn=41bda56f_25 "malaria-vaccine-first-babies-500pix")